Lamotrigine
Brand name: Lamotrigine
Rank #177 of 500 drugs by total cost
$89.0M
Total Cost
1,603,798
Total Claims
$89.0M
Total Cost
35,357
Prescribers
$55
Cost per Claim
177,029
Beneficiaries
2,422,948
30-Day Fills
$2,516
Avg Cost/Provider
45
Avg Claims/Provider
About Lamotrigine
Lamotrigine (sold as Lamotrigine) was prescribed 1,603,798 times by 35,357 Medicare Part D providers in 2023, costing the program $89.0M. At $55 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 174 | Mepolizumab (Nucala) | $90.1M | 20,798 |
| 175 | Finerenone (Kerendia) | $89.5M | 93,151 |
| 176 | Ixazomib Citrate (Ninlaro) | $89.0M | 6,901 |
| 177 | Lamotrigine (Lamotrigine) | $89.0M | 1,603,798 |
| 178 | Insulin Aspart Prot/Insuln Asp (Novolog Mix 70-30 Flexpen) | $88.8M | 79,814 |
| 179 | Teduglutide (Gattex) | $88.4M | 1,758 |
| 180 | Galcanezumab-Gnlm (Emgality Pen) | $87.0M | 101,221 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology